Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Grail
MedTech
EU court hands Illumina consolation prize over Grail deal
Though Illumina has already parted ways with Grail, the DNA sequencing giant will not have to pay the European Union its $476 million fine.
Conor Hale
Sep 3, 2024 12:21pm
Flying solo, Grail to cut 30% of staff, narrow cancer test focus
Aug 14, 2024 11:30am
Grail makes ground in massive U.S., U.K. clinical studies
Jul 17, 2024 10:29am
Illumina parts ways with Grail, with divestiture complete
Jun 24, 2024 5:01pm
Grail to become an Illumina spinout, once again, and go public
Jun 3, 2024 5:45pm
Illumina gets go-ahead from EU to part ways with Grail
Apr 12, 2024 10:11am
